Therabiopharma is part of the Kyoto University Life Science Showcase 2020, San Diego This event will introduce biotech startups with novel technologies and seeds from Kyoto University, Japan. Therabipharma will
Therabiopharma CEO held a presentation at NCN (Nutrition Capital Network) showcasing the latest innovations on nutraceuticals and pharmaceuticals. Nutrition Capital Network, a New Hope Network organization, facilitates financing and asset
Therabiopharma (Japan Based Bio-Venture) Reports 10,000 Times Higher Curcumin Concentration in Bloodstream Clearly Demonstrates Strong Efficacies with/without Oxaliplatin in an Animal Study for Colon Cancer.
Our recent progress on a water-soluble curcumin monoglucronide (CMG) will be presented at the GAP (Global Academic Programs) conference of Karolinska Institute in Sweden: Kanai, M., Imaizumi, A., Kakeya, H.
As collaborative research results with Kyoto University,Professor Masafumi Kanai (Graduate School of Medicine, Kyoto University ) announced the anticancer effect of the prodrug curcumin (CMG) at the 15th Annual Meeting